New findings detail how executives handle compliance challenges.
Egnyte commissioned GatePoint Research to query 152 executives in Regulatory Affairs, R&D, Clinical and Quality about the challenges facing data-driven, mission-critical companies as they try to maintain GxP compliance, specifically around data integrity and data privacy and security.
The report looks at how the biotechs efficiently and securely manage collaboration and data and unveils some interesting results. One of the findings is that the most popular applications used to manage regulated data are not designed for life sciences specifically. In such a specialized field, this can lead to trouble.
Another finding the report points to is a divide developing amongst life scenes organizations. There are technology adopters and there are organizations that still operate from manual processes leading to friction in collaborating with partners and difficulty maintaining compliance with regulations.
